Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Liraglutide
Related studies linked through entity extraction aliases.
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
- Status
- COMPLETED
- Phase
- PHASE4
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults
- Status
- UNKNOWN
- Phase
- PHASE3
Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
- Status
- COMPLETED
- Phase
- PHASE3
Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Condition in Giant Obese Patients
- Status
- COMPLETED
- Phase
- PHASE4
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
- Status
- COMPLETED
- Phase
- PHASE3
Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
- Status
- COMPLETED
- Phase
- PHASE4
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Antiproteinuric Effects of Liraglutide Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
- Status
- UNKNOWN
- Phase
- PHASE4
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Liraglutide in Adolescents With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Glucagon Like Peptide-1 on No-reflow
- Status
- UNKNOWN
- Phase
- NA
A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
- Status
- COMPLETED
- Phase
- PHASE3
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
- Status
- UNKNOWN
- Phase
- PHASE4
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
- Status
- TERMINATED
- Phase
- PHASE2
Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
- Status
- UNKNOWN
- Phase
- NA